Back
Results - Announcements
Shree Ganesh Remedies Ltd consolidated sales down 56.75% on year in Q2FY2026, net profit plunged by 82.14%
12-Aug-2026, 08:06
Shree Ganesh Remedies Ltd share price ticked higher by 2.42% to Rs 621.15. The Company's net profit tumbled by 82.14% to Rs 1.12 crore, while revenue from operations nosedived 56.75% to Rs 14.36 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.12 lakh crore, easing 4.31%. It has improved by 0.98% over last one week and climbed by 11.49% in last one month while the market capitalization of Shree Ganesh Remedies Ltd has softened by 5.56% and 22.40% in the same period respectively. Profit before tax (PBT) of Shree Ganesh Remedies Ltd stood at Rs 1.53 crore in Q2 FY26, nosediving by 66.74% year-on-year, and tanking 82.45% quarter-on-quarter. EBITDA came in at Rs 2 crore, tumbling by 63.70% YoY and plunging by 76.74% sequentially. Total expenses slumped by 45.37% to Rs 13.45 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 8.4 crore, registering a fall of 23.84% YoY, while employee benefits expense was at Rs 2.93 crore, ticking higher by 2.09% YoY. For the TTM ended FY26, revenue from operations dropped by 13.74% to Rs 108.6 crore, while net profit fell 17.93% to Rs 23.07 crore, compared to previous TTM. EBITDA soared by 4120% to Rs 35.49 crore, and PBT contracted 18.06% to Rs 31.27 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 0.0 crore in FY26, as against Rs 30.45 crore in FY25. Shree Ganesh Remedies Ltd rallied 18.39% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 3.04% during the same period.
Shree Ganesh Remedies Ltd share price ticked higher by 2.42% to Rs 621.15. The Company's net profit tumbled by 82.14% to Rs 1.12 crore, while revenue from operations nosedived 56.75% to Rs 14.36 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.12 lakh crore, easing 4.31%. It has improved by 0.98% over last one week and climbed by 11.49% in last one month while the market capitalization of Shree Ganesh Remedies Ltd has softened by 5.56% and 22.40% in the same period respectively. Profit before tax (PBT) of Shree Ganesh Remedies Ltd stood at Rs 1.53 crore in Q2 FY26, nosediving by 66.74% year-on-year, and tanking 82.45% quarter-on-quarter. EBITDA came in at Rs 2 crore, tumbling by 63.70% YoY and plunging by 76.74% sequentially. Total expenses slumped by 45.37% to Rs 13.45 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 8.4 crore, registering a fall of 23.84% YoY, while employee benefits expense was at Rs 2.93 crore, ticking higher by 2.09% YoY. For the TTM ended FY26, revenue from operations dropped by 13.74% to Rs 108.6 crore, while net profit fell 17.93% to Rs 23.07 crore, compared to previous TTM. EBITDA soared by 4120% to Rs 35.49 crore, and PBT contracted 18.06% to Rs 31.27 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 0.0 crore in FY26, as against Rs 30.45 crore in FY25. Shree Ganesh Remedies Ltd rallied 18.39% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 3.04% during the same period.